Xolair 150 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FNMXK
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,211
Award facts
- Contract value 100% obligated
- $23,211.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $23,211 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for XOLAIR 150 mg/ml syringes, with an ultimate completion date of October 9, 2025. This delivery order was issued without a set-aside designation and represents a single line item fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at $499,999,999 and valid through November 2026. The contract will be performed in Park Ridge, Illinois, where the vendor is based.
DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler that has established itself as a critical supplier within the federal pharmaceutical supply chain, particularly for the Department of Defense. The company specializes in distributing branded and generic prescription drugs, biologics, over-the-counter medications, and medical consumables to military and federal healthcare facilities nationwide. XOLAIR (omalizumab), a monoclonal antibody used in treating asthma and allergic conditions, represents the type of specialty pharmaceutical product the vendor routinely supplies to support military health system operations. The company's established portfolio of federal contracts demonstrates consistent capability to deliver diverse pharmaceutical products meeting DoD medical supply requirements.
Quick answers
Who was awarded contract SPE2DB25FNMXK?
SPE2DB25FNMXK was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 18, 2025.
How much is contract SPE2DB25FNMXK worth?
The government has obligated $23,211 on SPE2DB25FNMXK.
Is contract SPE2DB25FNMXK an order under another contract?
Yes. SPE2DB25FNMXK is a delivery order under SPE2DB25D9348, an indefinite delivery contract.
Was contract SPE2DB25FNMXK competed?
The extent of competition for SPE2DB25FNMXK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award